Cryopreservation of Hemopoietic Cells for Allotransplant: Altered Immune Cell Subsets and Clinical Implications
American Journal of Hematology · 2026-05 · 101 (5) · 1036-1044
DOI: 10.1002/ajh.70255 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, online erschienen am 04.03.2026. Verfasst von Anna Maria Raiola und 19 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Cellular Therapy Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy. Hauptthemen laut MEDLINE: Cryopreservation, Graft vs Host Disease, Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cells. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Associazione Italiana Contro le Leucemie-Linfomi e Mieloma.
Abstract (Originalsprache)
Cryopreservation of allogeneic peripheral blood stem cells was widely adopted during the SARS‐CoV‐2 pandemic. We evaluated transplant‐related complications and graft product composition in a retrospective ( n = 62) and prospective ( n = 47) series of patients transplanted from an HLA‐identical donor comparing cryopreserved ( n = 50) versus fresh ( n = 59) peripheral blood stem cell grafts. Primary endpoints were hematological reconstitution and cumulative incidence of grade II–IV acute graft versus host disease. Median times to neutrophil and platelet recovery were longer in the cryopreserved group compared with the fresh group: 18 vs. 16 days ( p < 0.001) and 20 vs. 14 days ( p < 0.001), respectively. The cumulative incidence of grade II–IV acute graft versus host disease at day 100 and of poor graft function at 1 year was significantly higher in the cryopreserved group: 34% vs. 10.1%, ( p = 0.0017) and 20% vs. 1.6% ( p < 0.001), respectively. To characterize immune cell profiles in fresh and cryopreserved samples, a representative subset was analyzed by mass cytometry, revealing a higher number of T‐cell populations known to modulate immune responses and promote graft engraftment in fresh samples. Thus, cryopreservation of allogeneic peripheral blood stem cells is associated with increased incidence of acute graft versus host disease and poor graft function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Hematology and Cellular Therapy Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
- Department of Internal Medicine (DIMI), University of Genoa, Genoa e IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
- Department of Experimental Medicine (DIMES), Università di Genova, Genova, Italy.
ORCID-Profile: Luca Barabino, Emanuele Angelucci
Förderung
- Associazione Italiana Contro le Leucemie-Linfomi e Mieloma
Zitieren
APA
Raiola, A. M., Contini, P., Gambella, M., Barabino, L., Bregante, S., di Grazia, C., Dominietto, A., Ghiso, A., Guastalla, A., Marri, L., Serio, A., Luchetti, S., Varaldo, R., Laudisi, A., Francia, G., Passannante, M., Ivaldi, F., Bo, A., De Palma, R., & Angelucci, E. (2026). Cryopreservation of Hemopoietic Cells for Allotransplant: Altered Immune Cell Subsets and Clinical Implications. American Journal of Hematology, 101(5), 1036-1044. https://doi.org/10.1002/ajh.70255
Vancouver
Raiola AM, Contini P, Gambella M, Barabino L, Bregante S, di Grazia C, et al. Cryopreservation of Hemopoietic Cells for Allotransplant: Altered Immune Cell Subsets and Clinical Implications. American Journal of Hematology. 2026;101(5):1036-1044. doi:10.1002/ajh.70255
BibTeX
@article{Raiola2026,
author = {Raiola, Anna Maria and Contini, Paola and Gambella, Massimiliano and Barabino, Luca and Bregante, Stefania and di Grazia, Carmen and Dominietto, Alida and Ghiso, Anna and Guastalla, Andrea and Marri, Luca and Serio, Alberto and Luchetti, Silvia and Varaldo, Riccardo and Laudisi, Antonella and Francia, Giulia and Passannante, Monica and Ivaldi, Federico and Bo, Alessandra and De Palma, Raffaele and Angelucci, Emanuele},
title = {Cryopreservation of Hemopoietic Cells for Allotransplant: Altered Immune Cell Subsets and Clinical Implications},
journal = {American Journal of Hematology},
year = {2026},
volume = {101},
number = {5},
pages = {1036--1044},
doi = {10.1002/ajh.70255}
}
EUVIMED